secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K
Filed at:   2025-06-16T23:59:59+00:00
Accession:  0001213900-25-054501
Event type: regulatory
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Onconetix granted Nasdaq continued listing; completes reverse stock split to meet bid price rule
--------------------------------------------------------------------------------

- Nasdaq Hearings Panel granted continued listing on June 11, 2025, subject to compliance by June 30, 2025.
- Company met periodic filing rule by filing Q1 10-Q on June 12, 2025.
- Completed 1-for-85 reverse stock split on June 13, 2025 to address bid price requirement.
- Expects to demonstrate compliance with bid price rule by close of business June 27, 2025.
- Hearing held May 27, 2025; company's request for continued listing was granted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390025054501/0001213900-25-054501-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390025054501/ea0245818-8k_onconetix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-054501

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer